ANGIE FINKEL: Open Payments
NPI 1023527876 · PENSACOLA, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,234 in 71 payments from 20 companies in 2025. Trend: 2023 $755 · 2024 $993 · 2025 $1,234
Food & beverage: $1,234
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 12 | $174 |
| PFIZER INC. | 9 | $166 |
| Novo Nordisk Inc | 12 | $139 |
| ABBVIE INC. | 6 | $123 |
| Radius Health, Inc. | 4 | $86 |
| Astellas Pharma US Inc | 3 | $56 |
| Corcept Therapeutics | 2 | $56 |
| Amgen Inc. | 3 | $49 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $49 |
| GlaxoSmithKline, LLC. | 3 | $48 |
Products named: NURTEC ODT, MOUNJARO, Wegovy, Tymlos, VRAYLAR, JARDIANCE, Veozah, Korlym.
Industry payments across FL — which companies pay providers there.
